Your browser doesn't support javascript.
loading
In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
Cuba, Gabriel T; Santos, Paulo H D; Pignatari, Antonio C C; Nicolau, David P; Kiffer, Carlos R V.
Affiliation
  • Cuba GT; Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina, São Paulo, SP, Brazil; Universidade de São Paulo (HCFMUSP), Hospital das Clínicas, Faculdade de Medicina, São Paulo, SP, Brazil. Electronic address: gbtrova@gmail.com.
  • Santos PHD; Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina, São Paulo, SP, Brazil.
  • Pignatari ACC; Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina, São Paulo, SP, Brazil.
  • Nicolau DP; Center of Anti-infective Research and Development, Hartford Hospital, Hartford, CT, United States.
  • Kiffer CRV; Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina, São Paulo, SP, Brazil.
Braz J Infect Dis ; 26(2): 102355, 2022.
Article in En | MEDLINE | ID: mdl-35490771
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas Infections / Amikacin Limits: Humans Language: En Journal: Braz J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication: Brazil
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pseudomonas Infections / Amikacin Limits: Humans Language: En Journal: Braz J Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Document type: Article Country of publication: Brazil